<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29432158</article-id>
<article-id pub-id-type="pmc">5828603</article-id>
<article-id pub-id-type="publisher-id">201716092</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1716092115</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>PNAS Plus</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Genetics</subject>
</subj-group>
</subj-group>
<series-title>PNAS Plus</series-title>
</article-categories>
<title-group>
<article-title>16p11.2 transcription factor <italic>MAZ</italic> is a dosage-sensitive regulator of genitourinary development</article-title>
<alt-title alt-title-type="short"><italic>MAZ</italic> regulates genitourinary development</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Haller</surname>
<given-names>Meade</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Au</surname>
<given-names>Jason</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>O’Neill</surname>
<given-names>Marisol</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lamb</surname>
<given-names>Dolores J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Molecular and Cellular Biology, <institution>Baylor College of Medicine</institution>, Houston, <addr-line>TX</addr-line> 77030;</aff>
<aff id="aff2"><sup>b</sup>Center for Reproductive Medicine, <institution>Baylor College of Medicine</institution>, Houston, <addr-line>TX</addr-line> 77030;</aff>
<aff id="aff3"><sup>c</sup>Department of Urology, <institution>Baylor College of Medicine</institution>, Houston, <addr-line>TX</addr-line> 77030</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>m.haller@wustl.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Frank Costantini, Columbia University, New York, NY, and accepted by Editorial Board Member Kathryn V. Anderson January 12, 2018 (received for review September 12, 2017)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: M.H. and D.J.L. designed research; M.H., J.A., and M.O. performed research; D.J.L. contributed new reagents/analytic tools; M.H., M.O., and D.J.L. analyzed data; and M.H. and D.J.L. wrote the paper.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>20</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>2</month>
<year>2018</year>
</pub-date>
<volume>115</volume>
<issue>8</issue>
<fpage>E1849</fpage>
<lpage>E1858</lpage>
<permissions>
<copyright-year>2018</copyright-year>
<license>
<license-p>Published under the <ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/site/aboutpnas/licenses.xhtml">PNAS license</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201716092.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Copy number gains and losses have long been studied as the potential causes of various congenital defects. Urogenital birth defects account for as many at 30% of structural anomalies, and the 16p11.2 genetic locus is among the most common copy variant regions. Herein is shown that variation in copy number of the transcription factor <italic>MA</italic><italic>Z</italic>, located within the 16p11.2 locus, contributes significantly to a wide range of the urogenital birth defects associated with this genomic syndrome, including structural abnormalities of the developing kidneys, ureters, and bladder. Understanding large chromosomal aberrations by studying the functions of individual developmental genes at each variant locus will pave the way for future targeted therapies in affected pregnancies.</p>
</abstract>
<abstract>
<p>Genitourinary (GU) birth defects are among the most common yet least studied congenital malformations. Congenital anomalies of the kidney and urinary tract (CAKUTs) have high morbidity and mortality rates and account for ∼30% of structural birth defects. Copy number variation (CNV) mapping revealed that 16p11.2 is a hotspot for GU development. The only gene covered collectively by all of the mapped GU-patient CNVs was MYC-associated zinc finger transcription factor (<italic>MAZ</italic>), and <italic>MAZ</italic> CNV frequency is enriched in nonsyndromic GU-abnormal patients. Knockdown of <italic>MAZ</italic> in HEK293 cells results in differential expression of several WNT morphogens required for normal GU development, including Wnt11 and Wnt4. <italic>MAZ</italic> knockdown also prevents efficient transition into S phase, affects transcription of cell-cycle regulators, and abrogates growth of human embryonic kidney cells. Murine <italic>Maz</italic> is ubiquitously expressed, and a CRISPR-Cas9 mouse model of <italic>Maz</italic> deletion results in perinatal lethality with survival rates dependent on <italic>Maz</italic> copy number. Homozygous loss of <italic>Maz</italic> results in high penetrance of CAKUTs, and <italic>Maz</italic> is haploinsufficient for normal bladder development. <italic>MAZ</italic>, once thought to be a simple housekeeping gene, encodes a dosage-sensitive transcription factor that regulates urogenital development and contributes to both nonsyndromic congenital malformations of the GU tract as well as the 16p11.2 phenotype.</p>
</abstract>
<kwd-group>
<kwd>genitourinary</kwd>
<kwd>copy number variation</kwd>
<kwd>transcription factor</kwd>
<kwd>haploinsufficient</kwd>
<kwd>CAKUT</kwd>
</kwd-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>